{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:42:57Z","timestamp":1788838977968,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ejim.2011.09.005","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T21:41:00Z","timestamp":1320097260000},"page":"110-117","source":"Crossref","is-referenced-by-count":19,"title":["Excessive daytime sleepiness and narcolepsy \u2014 An approach to investigation and management"],"prefix":"10.1016","volume":"23","author":[{"given":"Ian","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata L.","family":"Riha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.09.005_bb0005","unstructured":"International Classification of Sleep Disorders, 2nd Ed, Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine 2006."},{"key":"10.1016\/j.ejim.2011.09.005_bb0010","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/sleep\/30.12.1712","article-title":"Treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Wise","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/sj.npp.1300991","article-title":"Modafinil attenuates disruptions in cognitive performance during simulated night-shift work","volume":"31","author":"Hart","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/sleep\/29.9.1189","article-title":"A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy","volume":"29","author":"Weaver","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1365-2796.1996.475826000.x","article-title":"Daytime sleepiness in an adult, Finnish population","volume":"239","author":"Hublin","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/sleep\/4.2.147","article-title":"Sleep habits and sleep disturbances in industrial workers in Israel: main findings and some characteristics of workers complaining of excessive daytime sleepiness","volume":"4","author":"Lavie","year":"1981","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.1992.tb05097.x","article-title":"Daytime sleepiness: a risk factor in community life","volume":"86","author":"Martikainen","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ejim.2011.09.005_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.smrv.2008.01.001","article-title":"From wakefulness to excessive sleepiness: what we know and still need to know","volume":"12","author":"Ohayon","year":"2008","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.ejim.2011.09.005_bb0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0050","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S1388-2457(99)00167-4","article-title":"Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy","volume":"110","author":"Sangal","year":"1999","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.sleep.2006.08.012","article-title":"Why do we continue to use Epworth sleepiness scale?[letter]","volume":"8","author":"Tachibana","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/sleep\/15.3.268","article-title":"The clinical use of the Multiple Sleep Latency Test. The standards of practice committee of the American Sleep Disorders Association","volume":"15","author":"Thorpy","year":"1992","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0065","first-page":"620","article-title":"Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy","volume":"20","author":"Aldrich","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0070","series-title":"European Respiratory Society Annual Congress","article-title":"Multiple sleep latency testing in the United Kingdom and Europe (poster presentation)","author":"Riha","year":"2006"},{"key":"10.1016\/j.ejim.2011.09.005_bb0075","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1468-1331.2010.03223.x","article-title":"Diagnosing narcolepsy with cataplexy on history alone: challenging the International Classification of Sleep Disorders (ICSD-2) criteria","volume":"18","author":"Morrison","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0080","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0085","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/sleep\/29.11.1439","article-title":"Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1\/orexin-A findings","volume":"29","author":"Oka","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/sleep\/33.2.169","article-title":"Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population","volume":"33","author":"Knudsen","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0095","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/sleep\/17.suppl_8.S7","article-title":"Epidemiology of narcolepsy","volume":"17","author":"Hublin","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1212\/WNL.58.12.1826","article-title":"Prevalence of narcolepsy symptomatology and diagnosis in the European general population","volume":"58","author":"Ohayon","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0110","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410320103","article-title":"Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder","volume":"32","author":"Schenck","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.sleep.2004.11.007","article-title":"The association between narcolepsy and REM behavior disorder (RBD)","volume":"6","author":"Nightingale","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004691-200103000-00002","article-title":"Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives","volume":"18","author":"Overeem","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/sleep\/9.1.254","article-title":"Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients","volume":"9","author":"Honda","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0135","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(05)74704-8","article-title":"Increased body-mass index in patients with narcolepsy","volume":"355","author":"Schuld","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.09.005_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/sleep\/19.1.75","article-title":"Spontaneous food choice in narcolepsy.[letter]","volume":"19","author":"Lammers","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0091-3057(97)00241-4","article-title":"Circadian temperature and activity rhythms in unmedicated narcoleptic patients","volume":"58","author":"Mayer","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.ejim.2011.09.005_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0155","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/sleep\/32.11.1491","article-title":"Body mass index-independent metabolic alterations in narcolepsy with cataplexy","volume":"32","author":"Poli","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0160","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.88.8.3475","article-title":"Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment","volume":"88","author":"Mignot","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejim.2011.09.005_bb0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2011.09.005_bb0170","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejim.2011.09.005_bb0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/pr.109.001321","article-title":"Orexin\/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system","volume":"61","author":"Tsujino","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ejim.2011.09.005_bb0185","first-page":"220","article-title":"Clinical features and aetiology","volume":"17","author":"Narcolepsy","year":"1985","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.ejim.2011.09.005_bb0190","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","article-title":"HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group","volume":"51","author":"Pelin","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.ejim.2011.09.005_bb0200","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejim.2011.09.005_bb0205","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1389-9457(00)00082-4","article-title":"Hypersomnia due to acute disseminated encephalomyelitis in a 5-year-old girl","volume":"2","author":"Kanbayashi","year":"2001","journal-title":"Sleep Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0215","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.39.11.1505","article-title":"Narcolepsy associated with lesions of the diencephalon","volume":"39","author":"Aldrich","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.61.5.758","article-title":"Narcolepsy caused by acute disseminated encephalomyelitis","volume":"61","author":"Gledhill","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1212\/WNL.30.1.105","article-title":"Multiple sclerosis and narcolepsy\/cataplexy in a monozygotic twin","volume":"30","author":"Schrader","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0230","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2011.09.005_bb0235","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2011.09.005_bb0240","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0245","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00415-007-0594-8","article-title":"Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy","volume":"254","author":"Fronczek","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0250","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00415-008-0996-2","article-title":"No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy","volume":"255","author":"Valko","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0255","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181bd1344","article-title":"Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment","volume":"73","author":"Dauvilliers","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.smrv.2007.07.010","article-title":"Narcolepsy: immunological aspects","volume":"12","author":"Overeem","year":"2008","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.ejim.2011.09.005_bb0265","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0270","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-1331.2006.01473.x","article-title":"EFNS guidelines on management of narcolepsy","volume":"13","author":"Billiard","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.43.1_Part_1.55","article-title":"The positive diagnosis of narcolepsy and narcolepsy's borderland","volume":"43","author":"Moscovitch","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0280","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0285","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0301-0082(93)90042-Q","article-title":"The neurobiology of narcolepsy\u2013cataplexy","volume":"41","author":"Aldrich","year":"1993","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/appi.neuropsych.17.3.405","article-title":"Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness","volume":"17","author":"Schwartz","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ejim.2011.09.005_bb0295","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00002826-200403000-00005","article-title":"Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness","volume":"27","author":"Schwartz","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0300","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00002826-200309000-00009","article-title":"Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy","volume":"26","author":"Schwartz","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0305","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0310","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy","volume":"1","year":"2005","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0315","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ejim.2011.09.005_bb0320","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2006.09.005","article-title":"Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors","volume":"52","author":"Korotkova","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0325","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(92)91713-O","article-title":"Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat","volume":"591","author":"Lin","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.ejim.2011.09.005_bb0330","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.93.24.14128","article-title":"Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat","volume":"93","author":"Lin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejim.2011.09.005_bb0335","first-page":"19","article-title":"Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study","volume":"27","author":"Gallopin","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0340","first-page":"11","article-title":"Modafinil: a drug in search of a mechanism","volume":"27","author":"Saper","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.ejim.2011.09.005_bb0350","unstructured":"European Medicines Agency. Press release. 2010."},{"key":"10.1016\/j.ejim.2011.09.005_bb0355","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ejim.2011.09.005_bb0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1556-4029.2006.00078.x","article-title":"Abusive prescription of psychostimulants: a study of two cases","volume":"51","author":"Pelissier-Alicot","year":"2006","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.ejim.2011.09.005_bb0365","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/BF01271186","article-title":"The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice","volume":"103","author":"Nissbrandt","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.ejim.2011.09.005_bb0370","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1749-6632.2002.tb04186.x","article-title":"Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB","volume":"965","author":"Itzhak","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejim.2011.09.005_bb0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(02)01502-9","article-title":"Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid","volume":"441","author":"Carai","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0380","first-page":"971","article-title":"Effect of gamma-hydroxybutyrate on locomotor activity and brain dopamine metabolism in the rat","volume":"27","author":"Bottiglieri","year":"2001","journal-title":"J Neurosci Abstr"},{"key":"10.1016\/j.ejim.2011.09.005_bb0385","article-title":"A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing","author":"George","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.ejim.2011.09.005_bb0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0395","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1212\/WNL.50.2_Suppl_1.S43","article-title":"Treatment modalities for narcolepsy","volume":"50","author":"Fry","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2011.09.005_bb0400","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","article-title":"Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ejim.2011.09.005_bb0405","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1001\/jama.1935.02760510023006","article-title":"The use of benzedrine for the treatment of narcolepsy","volume":"105","author":"Prinzmetal","year":"1935","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejim.2011.09.005_bb0410","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ejim.2011.09.005_bb0415","first-page":"CD003724","article-title":"Antidepressant drugs for narcolepsy","author":"Vignatelli","year":"2008","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T19:22:45Z","timestamp":1593199365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0953620511002184"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.09.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}